Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
People have relied on natural oils for centuries to soften skin and treat dryness, but not every oil is created equal. Squalane traces back to squalene, discovered in shark liver in the early 1900s. Japanese chemists worked out how to refine it, valuing its purity and stability. Over time, research unlocked plant-based alternatives, especially from olives, responding to sustainability concerns and animal welfare. By the mid-20th century, pharmacopoeias like BP, EP, and USP took notice, introducing pharmaceutical-grade squalane and creating standards for its use not just in creams but in medicine and industry as well.
Squalane stands as a fully saturated, hydrogenated derivative of squalene, prized for its non-oxidizing nature. Transparent and odorless, squalane brings a smooth touch, avoids greasiness and resists breakdown by heat, air, and light. Companies use pharmaceutical-grade squalane when they need the highest purity and batch consistency. With plant origins taking center stage, the industry mostly shifts toward olives and sugarcane, steering clear of shark-based sources to answer ethical calls from consumers and regulators.
Squalane gives off a colorless, clear liquid profile and carries a boiling point around 285–290°C. The molecular formula, C30H62, boasts a molar mass near 422.8 g/mol. Unlike squalene, which reacts readily, squalane barely budges in the presence of oxygen, making it last far longer in storage and in final products. With a low viscosity and a specific gravity close to 0.81–0.83 at 20°C, squalane blends well in oil-based formulas but never feels heavy on skin. Water solubility falls to nearly zero, and the refractive index runs between 1.448 and 1.454. This constellation of properties makes squalane stand out as a stable emollient in pharmaceuticals and cosmetics.
Manufacturers producing squalane for BP, EP, and USP grades follow rigorous impurity and identity tests. Total impurities like peroxides or heavy metals stay below 0.1%, confirmed via gas chromatography and mass spectrometry. Residue solvents must meet ICH and pharmacopoeial limits, especially to exclude traces of toluene or ethanol that pose toxicity risks. Labeling requires identification of plant source, molecular structure, grade, and country of origin. Batches include certificates of analysis and full traceability so downstream users, especially in pharma, can respond quickly if quality issues surface.
Refining squalane begins with harvesting squalene, once mostly pulled from deep-sea shark livers but now from olives and sugarcane. Extraction uses cold pressing or solvent techniques, with distillation following. Chemical hydrogenation converts squalene’s double bonds into single bonds, transforming it into squalane. Companies monitor every step, especially the removal of solvent remnants, unsaturated residues, and contaminants. Waste is minimized using water recirculation and by recycling byproducts back into energy generation, closing the loop on environmental impact.
Squalane resists chemical attacks that trouble other emollients. It doesn’t oxidize in air, holding off rancidity or color shifts in stored products. The saturated aliphatic structure means manufacturers don’t see polymerization, hydration, or oxidation like with its precursor squalene. Chemical modification plays a minor part here—rare exceptions include minor branching or the addition of cosmetic actives for multifunctional molecules. The backbone itself remains consistent batch after batch, offering reliability in formulation and shelf stability.
Many in the industry know squalane under several aliases, both in technical literature and on product labels: perhydrosqualene, dodecahydrosqualene, squalan, and hydrogenated squalene. Commercial brands add their touch, using names like Phytosqualan®, NeoSqualane™, and Plantasens®. All these permutations refer to the same saturated hydrocarbon at the core, and pharmacopoeial monographs tie these together, aiming for clarity in a global supply chain often at risk of confusion or fraud.
Toxicologists and regulators grade squalane as one of the safest emollients in pharmaceutical and topical use today. Non-sensitizing, non-irritating, and non-carcinogenic, it passes toxicity benchmarks in both animal and human studies. GMP and ISO 22716 certification underpin most reputable producers, creating a chain of custody from sourcing to shipping. Handling rarely needs personal protective equipment beyond standard gloves and goggles, mostly to keep material pure, not out of concern for exposure. Laboratories dealing with inhalation or bulk transfer maintain local exhaust or closed systems to protect purity and minimize workplace contamination.
Pharmaceutical-grade squalane fills more roles than most realize. Beyond lubricating skin in ointments and transdermal patches, squalane creates a delivery vehicle for actives, especially those sensitive to oxidation. Hospitals sometimes turn to it in sterile injections for lipophilic drugs. Personal care brands use it for face and body creams, serums, and sunscreens, counting on its feel and the fact that it doesn’t clog pores or spark breakouts. In the vaccine sector, derivatives of squalane stabilize adjuvants, boosting immune response while sticking to safety requirements. Some companies blend squalane with high-value botanicals to deliver sought-after “clean beauty” claims.
Development labs dive deep into the tissue compatibility and permeation characteristics squalane brings to delivery systems. Recent years saw a swell in microencapsulation and nanodispersion research, using squalane as a core carrier for unstable actives like retinoids or curated peptides. Collaborative work with universities explores synthetic biology, harnessing yeast or algae modified to crank out high-purity squalene, then hydrogenating it on scale to squalane. Such bioengineering aims not just for sustainability, but yield and traceability improvements that reassure both regulators and discerning buyers.
Decades of animal and clinical work shape our understanding of squalane’s safety. Long-term dermal studies in rats and rabbits show no adverse organ effects, nor teratogenicity or tumor formation. Patch tests in thousands of volunteers confirm low sensitization counts and rare incidents of dermatitis. In injection drug delivery, squalane fares well, presenting no acute toxicity or systemic reactions at therapeutic doses. Endocrine or reproductive toxicity doesn’t surface in multigenerational studies. Regulatory reviews in Europe, Asia, and the U.S. all converge: pharmaceutical-grade squalane checks the right boxes for minimal risk.
Global demand for squalane is climbing, led by a surge in conscious consumerism and high-performance skin treatments. Innovation centers on scaling biotech routes, using engineered microorganisms to produce squalene more efficiently and sustainably. Expect next-generation squalane forms, where microstructures or chemical conjugates add antioxidant or light-filtering properties. New regulatory frameworks will likely mandate tighter provenance tracking and sustainability audits, challenging suppliers to maintain transparency across continents. As research into delivery systems for mRNA vaccines or lipid nanoparticles expands, squalane’s role grows far beyond creams and lotions, embedding itself deeper in therapeutics and advanced medical applications. Scientific collaboration, not just product innovation, will map the road ahead.
Squalane has carved out a serious place in the pharmaceutical and personal care worlds. The "BP EP USP" tags mean it meets strict quality tests set by three health standards: British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). In real terms, this guarantees average consumers and health professionals can trust every batch for both purity and safety. Consistency like this matters a lot in products we use on our skin or take into the body, since these grades weed out contamination and unwanted by-products.
Growing up with eczema, I spent plenty of hours reading the backs of skin creams. Squalane stuck out, not just because it’s naturally derived (often from olives or sugarcane), but because doctors and pharmacists explained its safety for sensitive skin. Pharma-grade squalane works well in topical medicines—think of eczema lotions and ointments for burns—because it doesn’t clog pores, cause breakouts, or trigger allergic reactions. That hypoallergenic track record matters for the millions of folks dealing with skin flare-ups, rashes, or chronic dryness.
Drug developers often choose squalane as a carrier for active ingredients in topical medications. Its stable, lightweight texture helps spread medicines evenly across the skin, helping the other ingredients soak in without irritating the surface. Unlike petroleum-based alternatives, squalane doesn’t leave a greasy film, so patients are more likely to keep using their prescriptions. Plus, since it’s almost odorless and tasteless, some special capsules and oral supplements use it as a lubricant or coating that won’t react badly with bodily tissues.
Squalane isn’t just for the medicine cabinet. Its smooth feel makes it a go-to in moisturizers, serums, sunscreens, and makeup. My sister, who works at a spa, swears by products with pharma-grade squalane for sensitive clients. It seeps into skin easily, acting like a natural replacement for our body's own oils, which start to disappear as we age. Researchers have found that squalane helps seal moisture, prevents water loss, and doesn’t mess with the skin’s barrier. That’s a triple win for anyone dealing with dryness—especially in winter or in folks dealing with certain medical conditions.
Cosmetics companies lean on pharma-grade standards during product recalls and regulatory checks. Consumers trust that “pharma grade” means fewer additives, cutting out potential irritants. In the beauty world, trends come and go, but people keep searching for ingredients backed by research and a clean safety record.
Years ago, most squalane in the market came from shark liver. Now, green chemistry has changed the game. Today, olives, sugarcane, and even rice bran form the main sources, which not only eases pressure on endangered marine species but also makes production more ethical and scalable. Scientists keep refining ways to boost yield and reduce waste. The move toward plant-based sourcing also opens the door for vegan-friendly and cruelty-free products, helping companies keep up with what consumers now expect.
Pharma-grade squalane supports safer medicines and skincare, but it’s not immune from price swings or supply hiccups. Drought, crop diseases, or trade restrictions can cut the supply of plant-based feedstocks. Small tweaks in the supply chain ripple through to the end product, especially for manufacturers with global customers. Transparency and honest disclosure about sourcing help consumers choose brands aligned with their values and health needs.
Squalane has roots in natural sources like olives and sugarcane. For generations, people have sought out plant oils for their calming and moisturizing touch on the skin. Squalane takes its cue from nature, offering something light and stable, without the stickiness or rancid smell that plagues some plant oils. Traceability matters here. When squalane meets BP, EP, and USP benchmarks, it passes strong checks for purity, contaminant levels, and trace elements. Each batch faces tests in accredited labs, so rogue chemicals and heavy metals don’t sneak through.
Medicine and personal care can’t leave their reputation up to chance. BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) define what pharmaceutical grade means, and the people behind these standards constantly review them. Squalane that carries these grades pushes through defined hoops: purity becomes a number, contamination limits are strict, and every bottle matches the batch before it. Inspectors from government agencies in the US, Europe, and the UK require these grades for a reason. It’s not about blind trust—it’s about making sure raw ingredients actually behave the same way in every formula.
Squalane used on the skin delivers gentle, invisible moisture. Research doesn’t point to allergic reactions or irritation, even for those with sensitive skin or chronic conditions like eczema. Safety studies have tested squalane on humans and animals. Results reinforce that it both sits safely on the surface and isn’t absorbed deep enough to disrupt hormones or block pores. In my own experience working with personal care brands, clients’ top questions always center on “Will this make me break out?” Evidence says no, as squalane is non-comedogenic, even helping to balance oil levels in tricky skin types. Pharmacies stock squalane-based creams in baby products, burn creams, and anti-aging formulas—uses that demand extra caution.
Any substance can turn risky if manufacturing skips corners or if storage tanks build up residue. Fraud and cross-contamination exist, especially in industries with less oversight. Pharma-grade squalane can’t rely on trust alone. Every shipment comes with certificates of analysis and full documentation. Government inspectors run audits. Additives or knock-off substitutes would not pass the same fingerprint checks or survive quality control. This sort of scrutiny protects people not just in hospitals, but in everyday bathrooms and clinics. When squalane comes from a manufacturer meeting BP, EP, and USP grades, safety becomes traceable, and red flags appear early.
Quality matters, but so does sustainability in sourcing. Most modern squalane uses renewable plant sources, avoiding earlier versions from shark liver oil. Companies face environmental reporting requirements showing they’ve phased out threatened animal harvesting. For extra assurance, consumers and buyers should ask for origin proof and sustainability audits—these aren’t luxuries but now part of responsible purchasing. Laws have stepped in to close loopholes, and third-party verifications hold suppliers to their promises. Dermatologists, pharmacists, and product formulators continue to favor pharma-grade squalane, trusting its safety because transparency has become the new gold standard.
Squalane probably pops up more than most realize—in moisturizers, serums, sunblocks, and even some medicines. It's one of those ingredients that usually goes unnoticed unless you've spent evenings checking labels or researching safe skincare. Its claim to fame comes from its origin in olives, sugarcane, or sharks, but these days, most companies stick to plant-based sources. Squalane’s reputation for being lightweight and non-irritating draws attention, but not all squalane is created equal.
The difference starts at the very top with the words BP, EP, and USP—short for British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia. These references aren’t just industry jargon. They’re proof that a product meets strict safety and purity guidelines. Squalane with these marks goes through rigorous checks for contaminants, heavy metals, and even for residues from its production. This gives drug makers and medical formulators the confidence to use it in sensitive products—think injectable medicines, wound dressings, and high-end dermal treatments.
Walk into any beauty store. Most of the squalane sold there isn’t pharma grade. That doesn’t mean it’s low quality. Regular squalane also feels silky and does a solid job sealing in moisture. It’s produced using safe manufacturing methods, but doesn’t face the same scrutiny. Without strict pharmaceutical requirements, the focus lands on performance in cosmetics—hydration, smooth texture, and ease of absorption. For everyday skin or hair care, this works for most people. Still, folks with extra-sensitive skin or allergies might notice a difference.
In practice, pharma grade squalane often costs more. That price covers extensive testing—each batch is checked for purity (usually over 99%), microbiological content, and the absence of toxic byproducts. This level of quality is important for patients with compromised immune systems or anyone getting an implantable device. Doctors and manufacturers don’t want uncertainties in those situations. In the beauty aisle, companies have more leeway to balance purity with price. Even so, many top brands highlight the source and grade of squalane to calm sensitive or eco-conscious buyers.
I’ve noticed how people with skin conditions or allergies pay close attention to the source of their skincare ingredients. Pharma grade squalane offers peace of mind, especially for people who’ve had breakouts or reactions to less-tested products. Occasional stories circulate about contaminated raw materials—even low levels of impurities can build up over time or trigger allergies. For someone using a product every day, small differences start to matter.
One meaningful solution involves pushing for clear sourcing and transparency. Labels listing origin, grade, and certification allow shoppers to make better decisions. The industry benefits from closer collaboration among scientists, regulators, and producers to share new testing technologies that lower the cost of purity checks. For medical-grade suppliers, investing in clean biotechnology (like fermentation using engineered yeast) helps curb reliance on agricultural sources prone to pesticide contamination.
No one wants surprises in their medicine or skincare. Squalane that passes pharmaceutical standards isn’t just “cleaner”—it changes outcomes for doctors, patients, and cautious consumers. The right choice depends on needs. For some, high standards are vital; for others, a good moisturizer that feels right on the skin is all that matters.
Squalane’s reputation for skin and pharmaceutical use depends on keeping its purity protected at every turn. Squalane BP EP USP Pharma Grade stands out for its high quality, which is why its storage and handling cannot be treated like just any other chemical. If temperature, light, or environment get ignored, you risk contamination or deterioration. Having seen ingredient quality degrade from careless storage, I know overlooked details can lead to real-world problems—rejected products, extra costs, and safety risks that don’t hit the spreadsheets right away, but impact outcomes all the same.
Pharma-grade squalane asks for storage conditions that shield it from heat and sunlight. Temperatures ranging between 15°C and 30°C (59°F to 86°F) usually work best. Direct sunlight accelerates oxidation. Even a few days of sitting near a window or warehouse entrance has caused discoloration or a drop in transparency in my own experience. Squalane’s chemical stability under typical storage helps, but heat and ultraviolet light can still start subtle changes over time. Every small batch I’ve sent to a client after poor storage has come back with complaints, which is reason enough to recommend a cool, dry, shaded place.
Humidity makes a difference, though squalane itself isn’t hygroscopic. Moisture in the environment raises the risk of condensation inside containers. That opens the door for unwanted reactions, especially if packaging is opened frequently or sits unsealed. Stainless steel drums, amber glass bottles, or coated high-density polyethylene containers provide barriers that shield from air and moisture. Quality-minded labs always keep squalane sealed tight, and the difference is noticeable—a clearer, longer-lasting sample each time.
Handling squalane starts with personal protective gear, just like any high-purity raw material. Gloves prevent residues or contaminants from reaching the ingredient. Goggle use in the lab or warehouse isn’t just regulatory box-ticking—it prevents transfer of even trace materials. My training stressed vigilance about cross-contamination, and every GMP-compliant facility I’ve visited echoes this priority. Dedicated pumps and transfer lines make sense so there’s no leftover material from previous batches getting mixed in. Small actions here support traceability, keeping every shipment up to standard for audited production.
Each receiver or transfer should get labeled right away, with dates and batch codes tied into warehouse records. For larger operations, temperature and access monitoring deliver peace of mind—one unexpected HVAC malfunction can affect an entire batch’s shelf life. I’ve seen facilities use color-changing indicators or automated alerts that catch issues long before they reach the production line. Recording basic details builds accountability and transparency, aligning with industry expectations for pharmaceutical-grade materials.
Squalane leaks or spills cause slippery floors and possible workplace accidents, so quick cleanup using absorbent material and proper disposal according to local environmental health rules protects both people and ecosystem. Fire isn’t a big concern here, as squalane is stable and not especially volatile, but keeping it clear of strong oxidizers or acids helps maintain safe storage conditions. Routine audits and staff reminders keep everyone following best practices, even after procedures start to feel routine.
For anyone serious about squalane quality, small paperwork steps, steady environmental control, and everyday vigilance pay long-term dividends. Care in storage and handling isn’t just about ticking off regulatory requirements—it’s about protecting people, processes, and the finished product.
Step into any pharmacy or skincare aisle and squalane is close by, quietly boosting lotions, serums, and even injectable emollients. In the pharmaceutical world, purity isn’t a marketing slogan—it’s the law, and the stakes reach straight into patient safety. So the question comes up: does squalane labeled as BP, EP, and USP pharma grade check all the worldwide benchmarks outlined in international pharmacopeias?
BP stands for British Pharmacopoeia, EP for European Pharmacopoeia, and USP means United States Pharmacopeia. To earn even one of these marks, squalane goes through rigorous chemical scrutiny. The key criteria aren’t complicated: it must be highly purified, show almost no trace of contaminants, sit within narrow ranges for viscosity and clarity, and demonstrate stable physicochemical characteristics.
To hold all three badges—BP, EP, and USP—manufacturers certify squalane through repeated testing, batch after batch. Data from publicly available pharmacopeias requires that hydrocarbons remain incredibly stable, do not break down under heat or light, and keep impurities like polycyclic aromatic hydrocarbons well below known thresholds. Squalane can’t just look clear; it has to deliver actual safety and push no allergic or toxic red flags, regardless of whether a patient is swallowing it in a capsule or letting it soak into the skin.
In my time working alongside pharmaceutical companies, I’ve seen first-hand how raw material supply chains work. Even the best-credentialed ingredient may run into snags: a batch doesn’t meet water content rules, or the hydrocarbon profile falls out of spec. Compliance doesn’t stop after receiving a certificate of analysis—a team samples every shipment in an internal lab. I’ve watched quality control staff run repeated FTIR scans, analyze gas chromatography results, and sometimes reject truckloads because a reading ticked beyond acceptable limits.
Squalane, coming chiefly from either sugarcane or olives, also faces scrutiny for its supply chain transparency. Traceability and origin play a growing role in compliance with pharmacopeias, especially with EP rules demanding full documentation. If a company sources squalane that claims pharma grade, auditors from regulatory authorities can show up—and they will comb through not just test results but also records tracking every container back to its harvest.
Squalane sticking to global pharma standards goes far beyond paperwork. For pharmaceutical companies, this reduces batch recalls and bolsters trust. For patients, it’s about knowing a cream on a hospital tray will be free from concerning byproducts. Unwanted side reactions and degradation products have caused safety recalls in the past; tightly following BP, EP, and USP specs trims those risks.
It’s pretty common to see confusion on labels, though, especially as brands chase global sales. BP, EP, and USP can get tossed around as buzzwords, even if the manufacturer's last audit happened years ago. Third-party verification steps in here, bringing muscle to what’s printed on a drum or delivery slip. The FDA, EMA, and MHRA make routine rounds, running their own checks that sometimes outstrip manufacturer promises.
Materials like squalane will always face pressure to evolve in response to new research and guidance. Companies selling into different countries see benefit in aligning with all major pharmacopeias, avoiding border holdups, and smoothing regulatory approval. Digitized supply chain systems and barcoded batch tracking already lift the documentation burden and create more trust for buyers and patients alike.
From what I’ve seen and the data I review, squalane labeled as BP EP USP pharma grade signals strong alignment with international requirements, but the real proof lives in each batch delivered and independently tested. That’s how you safeguard trust in the supply chain—batch by batch, file by file, all under the wary eye of both regulators and, most importantly, the people who rely on safe medicines every day.
| Properties | |
| Viscosity | Viscosity: 28-35 cSt (at 40°C) |
Chengguan District, Lanzhou, Gansu, China
